tenofovir disoproxil
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of adults and children (weighing at least 40 kg) infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 245 mg ATC: J05AR27
Manufacturer: Maylan Laboratories Limited
-
The drug is intended for the treatment of adults infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 245 mg ATC: J05AR
Manufacturer: Aurobindo Pharma Limited - Unit VII
-
Dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets 50 mg/300 mg/300 mg is intended for the treatment of adults and children aged 12 years and older (weighing more than 40 kg) infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 300 mg ATC: J05AR
Manufacturer: Lupin Limited
-
Efavirenz, lamivudine and tenofovir disoproxil fumarate is indicated for the treatment of HIV infection (human immunodeficiency virus type 1) in adults and children aged 10 years and older weighing more than 35 kg.
Form: tablets, film-coated
Active substance Dosage efavirenz 600 mg lamivudine 300 mg tenofovir disoproxil 245 mg ATC: J05AR11
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is indicated for the treatment of adults and children aged 12 years and older (weighing at least 40 kg) who are infected with the human immunodeficiency virus (HIV).
Form: tablets, film-coated
Active substance Dosage dolutegravir 50 mg lamivudine 300 mg tenofovir disoproxil 300 mg ATC: J05AR27
Manufacturer: Hetero Labs Limited